SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-21-009457
Filing Date
2021-08-26
Accepted
2021-08-26 14:32:44
Documents
15
Period of Report
2021-08-20
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT amar_8k.htm   iXBRL 8-K 25016
2 CODE OF ETHICS amar_ex141.htm EX-14.1 60299
  Complete submission text file 0001654954-21-009457.txt   216004

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA amar-20210820.xsd EX-101.SCH 5595
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE amar-20210820_cal.xml EX-101.CAL 890
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amar-20210820_def.xml EX-101.DEF 2097
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE amar-20210820_lab.xml EX-101.LAB 13842
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amar-20210820_pre.xml EX-101.PRE 8738
8 EXTRACTED XBRL INSTANCE DOCUMENT amar_8k_htm.xml XML 3391
Mailing Address AINOS, INC. 8880 RIO SAN DIEGO DRIVE SUITE 800 SAN DIEGO CA 92108
Business Address AINOS, INC. 8880 RIO SAN DIEGO DRIVE SUITE 800 SAN DIEGO CA 92108 858-869-2986
Ainos, Inc. (Filer) CIK: 0001014763 (see all company filings)

IRS No.: 751974352 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20791 | Film No.: 211211624
SIC: 2834 Pharmaceutical Preparations